VISITECT® CD4, developed by the Burnet Institute in Melbourne, Australia, is an affordable POC test that enables CD4 T-cell levels to be determined, quickly and conveniently, even in remote rural ...

The receipt of a positive draft evaluation report for the VISITECT® CD4 test from 300 specimens in the Kenyan clinical study suggests that the study is running on time, that the test has high ...

LONDON (Alliance News) - Omega Diagnostics Group PLC said it has received the first purchase orders for its Visitect CD4 350 cut-off test for HIV. This form of HIV test determines whether a patient ...

(Alliance News) - Omega Diagnostics Group PLC on Monday announced that its Visitect CD4 Advanced Disease test will be included in the Global Fund procurement list. Shares in Omega Diagnostics were up ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

H113. Performance was mixed with food intolerance 9% higher, infectious disease down 12% and allergy steady at 2%. On 31 October the company gave the latest Visitect CD4 test manufacturing update, ...

Omega Diagnostics, the medical testing developer that recently sold its Scottish manufacturing facility, has agreed terms for the sale of its CD4 testing business. Did you know with a Digital ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

Omega Diagnostics has sold its CD4 testing business to the same Chinese-owned firm that bought its Clackmannanshire manufacturing facility earlier this year. Did you know with a Digital Subscription ...